Approval of new drugs 1999-2007: comparison of the US, the EU and Japan situations

This report provides a comprehensive view of drug lag in the three regions. More detailed analyses are necessary in order for a more in-depth discussion of the background factors, impacts and measures for the drug lag,which is especially noticeable in Japan.